Breaking News

OrganaBio Launches Contract Cell Therapy Manufacturing Ops

To provide custom contract-, self-, and hybrid-manufacturing options for therapeutics developers.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

OrganaBio, LLC initiates GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development manufacturing for custom solutions for therapeutics developers. The company will leverage its tissue supply chains to manufacture clinical grade tissue and cellular raw materials derived from perinatal tissues and adult apheresis products for partners, as well as offer contract-, self-, and hybrid-manufacturing options within the facility.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters